Understanding physician-pharmaceutical industry interactions

New York: Cambridge University Press (2007)
  Copy   BIBTEX

Abstract

Physician-pharmaceutical industry interactions continue to generate heated debate in academic and public domains, both in the United States and abroad. Despite this, recent research suggests that physicians and physicians-in-training remain ignorant of the core issues and are ill-prepared to understand pharmaceutical industry promotion. There is a vast medical literature on this topic, but no single, concise resource. This book aims to fill that gap by providing a resource that explains the essential elements of this subject. The text makes the reader more aware of the key ethical issues and allows the reader to be a more savvy interpreter of industry promotion, have a heightened awareness of the public and medical legal consequences of some physician-pharmaceutical industry interactions, and be better equipped to handle real-life encounters with industry

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,098

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Analytics

Added to PP
2009-01-28

Downloads
35 (#471,495)

6 months
5 (#710,311)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Disease-mongering through clinical trials.María González-Moreno, Cristian Saborido & David Teira - 2015 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 51:11-18.
Attitudes of Future Doctors of Bangladesh to Pharmaceutical Incentives and Medical Ethics.Tonmoy Biswas & Darryl Macer - 2017 - Eubios Journal of Asian and International Bioethics 27 (3):70-80.

Add more citations

References found in this work

No references found.

Add more references